about
Do physicians communicate the adverse effects of medications that older patients want to hear?Review of the home care programmes for respiratory syncytial virus (RSV) prophylaxis in Ireland and The NetherlandsSwitching statin-treated patients from fenofibrate to the prescription omega-3 therapy icosapent ethyl: a retrospective case series.Stability of medicines after repackaging into multicompartment compliance aids: eight criteria for detection of visual alteration.Afatinib in advanced NSCLC: a profile of its use.Cocaine use is associated with a number of life-threatening cardiovascular complications that require careful treatmentCorrection to: Afatinib in advanced NSCLC: a profile of its use.A review on therapeutic drug monitoring of the mTOR class of immunosuppressants: everolimus and sirolimusLinezolid: first of a new drug class for Gram-positive infectionsWill the promise of the COX-2 selective NSAIDs come to fruition?Pirfenidone: a guide to its use in idiopathic pulmonary fibrosisNomegestrol acetate/estradiol: a guide to its use in oral contraceptionCharacteristics of individuals who prefer branded innovator over generic medicines: a New Zealand general population surveyBronchodilators are central to the management of stable chronic obstructive pulmonary disease in the elderlyHistamine H2 receptor antagonists and proton pump inhibitors: best options for gastro-oesophageal reflux in childrenQuantitative exploration of medication errors among older people: a systematic reviewReducing dose omission of prescribed medications in the hospital setting: a narrative reviewAndexanet alfa in the treatment of acute major bleeding related to apixaban and rivaroxaban: a profile of its use in the USABurosumab in X-linked hypophosphatemia: a profile of its use in the USACorrection to: Andexanet alfa in the treatment of acute major bleeding related to apixaban and rivaroxaban: a profile of its use in the USACorrection to: Fostamatinib in chronic immune thrombocytopenia: a profile of its use in the USACorrection to: Burosumab in X-linked hypophosphatemia: a profile of its use in the USAAripiprazole: a discussion on its clinical use in mania associated with bipolar I disorderBilastine in symptomatic allergic rhinoconjunctivitis and urticaria: a guide to its useEmtricitabine/tenofovir disoproxil fumarate in HIV-1 pre-exposure prophylaxis: a guide to its once-daily use in the EUErratum to: Tafamidis in transthyretin amyloidosis: a guide to its use in delaying peripheral neurological impairment in patients with stage 1 polyneuropathyFluticasone furoate/vilanterol dry-powder inhaler in asthma: a guide to its use in the EUNews from the 45th ESCP Symposium on Clinical Pharmacy, 4–6 October 2016, OsloNivolumab in previously treated patients with advanced renal cell carcinoma: a guide to its usePixantrone in relapsed or refractory aggressive non-Hodgkin’s lymphoma: a guide to its useTafamidis in transthyretin amyloidosis: a guide to its use in delaying peripheral neurological impairment in patients with stage 1 polyneuropathyTrifluridine/tipiracil in metastatic colorectal cancer: a guide to its useUridine triacetate in the emergency treatment of fluorouracil or capecitabine overdose or toxicity: a guide to its use9-Valent human papillomavirus recombinant vaccine (Gardasil® 9): a guide to its use in the EUAmbrisentan in pulmonary arterial hypertension: a guide to its use in the EUCationorm® (cationic emulsion eye drops) in dry eye disease: a guide to its useCollagenase Clostridium histolyticum in Dupuytren’s contracture: a guide to its use in the EUDaclatasvir in hepatitis C virus infection: a guide to its use in the EUDaratumumab in multiple myeloma: a guide to its use as monotherapy in the EUEribulin mesylate in previously treated patients with advanced liposarcoma: a guide to its use
P1433
Q35142125-3CF2BF62-6C50-48BF-9E76-924677AA7D91Q36582250-D8F48C3E-C40B-405F-94DC-702CE5D02967Q36712679-D29C3AEC-45A9-4E07-B45C-15BFB11F877FQ42362860-DE4B9E3E-A17D-4B49-9452-F3C900576D67Q52655265-DF8A2E56-314B-4708-BAD9-C16B60F47118Q53462099-548D737B-1AF1-4B99-9458-5A50EB590A96Q55359147-2B215079-AB73-48A4-8F55-762210BAADF7Q56035477-F337DD9C-12D6-4AAC-943E-6674ABD83B66Q56268959-A2A2099C-6EE2-4ACC-94E7-097F04899779Q56431030-9C1259B8-6EB4-47E4-B5F8-F997B52169DCQ56912267-B0BD80E5-4140-425B-8B4F-24833DA3388FQ57480856-A19A697B-F0EB-445F-8002-29A1DA77ADC1Q57765039-06777317-DE5A-4577-BA45-FE2FC3F82DB0Q57778037-97C4B6A7-CAC4-470F-BF8F-71E72797EEE7Q57804177-2F25916B-D8F8-4745-BF38-810B85E73430Q57928092-D41ADB67-E75C-40C9-B984-8899194A4E20Q58804816-8DD5656A-F284-4BE0-B6AA-6AF36F638729Q59137498-C05EB2EB-68EC-49B3-A09C-6621551162F5Q59137500-6BD67A27-48AB-44D8-BF30-5A09584F52C7Q59797136-612C6C26-2930-4867-B3DD-B63C57D928FCQ59797979-B7F5DD36-0267-4488-81BC-F2A73139D56FQ59809966-B1D00C1D-5704-4EC6-B246-19B69BA4FAD6Q60460571-016C0998-F44A-43CD-AFDA-1CCA0180131FQ60486285-54FA8A16-9664-4587-A8AF-741E238741A4Q60486287-030A0CD2-0917-4785-8AA7-E88ED5BAF476Q60486289-999D350E-B2CA-419C-8E27-513DD5606CE8Q60486291-2E67239B-D096-4555-A796-C48ABBC42DD7Q60486293-322A32A8-2758-4C2E-922E-3420C9AA172FQ60486295-A95E009C-142F-45AA-9CF9-55692217470FQ60486299-C26E1FD3-C4E0-4260-BA41-28722812D076Q60486301-092EA357-992B-4579-B64F-C89110EA0222Q60486303-FC42EB28-7C14-4211-8156-8D180B2AA9A2Q60486305-12B9BEB3-DAE5-4013-8412-35B0467BBAB5Q60486308-AF318E19-251C-4BA6-9A4B-32408B18E8B6Q60486311-93257E56-B4AF-42C0-99BB-402B6B2312E2Q60486312-56B4ACEC-54DE-402A-A631-FF31302AF4F7Q60486314-EC622CAA-750C-4FC5-9FAD-145F5F89690BQ60486316-9BCA7299-F0A5-459F-B450-F2C3B9C41897Q60486318-0A77237E-7D5E-4047-AA9D-F935BCF51C12Q60486320-253E32D8-D2B1-4CB2-9A85-CB2F315168A9
P1433
description
czasopismo naukowe
@pl
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift
@nl
wissenschaftliche Fachzeitschrift
@de
مجلة
@ar
name
Drugs and Therapy Perspectives
@ast
Drugs and Therapy Perspectives
@da
Drugs and Therapy Perspectives
@en
Drugs and Therapy Perspectives
@es
Drugs and Therapy Perspectives
@fi
Drugs and Therapy Perspectives
@fr
Drugs and Therapy Perspectives
@it
Drugs and Therapy Perspectives
@nb
Drugs and Therapy Perspectives
@nl
Drugs and Therapy Perspectives
@nn
type
label
Drugs and Therapy Perspectives
@ast
Drugs and Therapy Perspectives
@da
Drugs and Therapy Perspectives
@en
Drugs and Therapy Perspectives
@es
Drugs and Therapy Perspectives
@fi
Drugs and Therapy Perspectives
@fr
Drugs and Therapy Perspectives
@it
Drugs and Therapy Perspectives
@nb
Drugs and Therapy Perspectives
@nl
Drugs and Therapy Perspectives
@nn
altLabel
Drugs & Therapy Perspectives
@en
prefLabel
Drugs and Therapy Perspectives
@ast
Drugs and Therapy Perspectives
@da
Drugs and Therapy Perspectives
@en
Drugs and Therapy Perspectives
@es
Drugs and Therapy Perspectives
@fi
Drugs and Therapy Perspectives
@fr
Drugs and Therapy Perspectives
@it
Drugs and Therapy Perspectives
@nb
Drugs and Therapy Perspectives
@nl
Drugs and Therapy Perspectives
@nn
P3181
P1055
P1058
P1156
P1277
P1476
Drugs and Therapy Perspectives
@en